NUTROPIN INJECTIONS

NUTROPIN INJECTIONS

Description

Nutropin is produced using recombinant DNA technology and has the same amino acid sequence as Human Growth Hormone produced naturally in the human body. Recombinant growth hormone was cloned by Genentech scientists in 1979.

Nutropin HGH Injections are a Human Growth Hormone Therapy to treat AGHD | See the New Nuspin Nutropin HGH Shots from Genentech

ABOUT ADULT GROWTH HORMONE DEFICIENCY

Growth hormone (hGH or GH) doesn’t just contribute to physical growth in children. Adults need GH, too. In adults, GH is essential to the maintenance of healthy body composition and metabolism. When an adult’s body is unable to produce enough GH, he or she is said to have adult GH deficiency (AGHD).

HGH Deficiency in Adults Some people with adult growth hormone (hGH or GH) deficiency were not GH-deficient as children. These people are said to have adult-onset GH deficiency.

AGHD Onset The usual cause of adult-onset GH deficiency is damage to the pituitary gland, which is responsible for secreting GH. This damage is most commonly caused by one or more tumors in and around the pituitary. Such a tumor may compress the gland, or the damage may occur when the tumor is removed. The pituitary gland may also be damaged by infection, blood vessel disease, severe head injury, or radiation treatment for tumors of the head or neck.

Growth Hormone Deficiency Education

Growth hormone deficiency, GHD, is a pituitary disorder resulting in short stature and other physical ailments. GHD occurs when the production of growth hormone, secreted by the pituitary gland, is disrupted. Since growth hormone plays a critical role in stimulating body growth and development, and is involved in the production of muscle protein and in the breakdown of fats, a decrease in the hormone affects numerous body processes.

Turner syndrome affects approximately one in 2,500 female, live births. Turner syndrome is a chromosomal disorder that affects females exclusively and is characterized, in part, by short stature and ovarian dysfunction. It is caused by the absence of all or part of one of the X chromosomes.

Chronic renal insufficiency, CRI, affects about 3,000 children in the United States. It manifests through a gradual and progressive loss of the ability of the kidneys to excrete wastes, concentrate urine, and conserve electrolytes. Kidney transplants can help a child start growing normally again, but most children do not make up the growth lost prior to transplantation.

HGH Therapy Safety

Growth hormone should not be initiated to treat patients with acute critical illness due to complications following open heart or abdominal surgery, multiple accidental trauma or to patients having acute respiratory failure.

Growth Hormone should not be used for growth promotion in pediatric patients with closed epiphyses.Growth Hormone should not be used in patients with active neoplasia. Growth Hormone therapy should be discontinued if evidence of neoplasia develops. Patients with a history of an intracranial lesion should be examined frequently for progression or recurrence of the lesion.

Intracranial hypertension (IH) with papilledema, visual changes, headache, nausea, and/or vomiting has been reported in a small number of patients treated with Growth Hormone. Funduscopic examination of patients is recommended at the initiation and periodically during Growth Hormone therapy. Patients with CRI or Turner’s Syndrome may be at increased risk for development of IH.

Growth Hormone may reduce insulin sensitivity, particularly in obese individuals, patients should be observed for evidence of glucose intolerance. For patients with diabetes mellitus, the insulin dose may require adjustment when Growth Hormone therapy is instituted.

Experience with prolonged Growth Hormone treatment in adults is limited.

Adverse events frequently reported in adult patients were edema (41%), arthralgias and other joint disorders (27%). Thirty-five percent of childhood-onset adult Growth Hormone deficient subjects treated with Growth Hormone 0.025 mg/kg/day for 2 years had supraphysiologic levels of insulin-like growth factor-I (IGF-I) at some time during the study, which may carry unknown risks. During therapy, dosage should be decreased if required by the occurrence of side effects or excessive IGF-I levels.

Patients being treated with Growth Hormone (GH) should be informed of the potential benefits and risks associated with Growth Hormone therapy.

If you need a prescription for HGH, contact our hormone treatment center for information on how to get a doctor’s prescription for growth hormone injections. With your prescription you can purchase Nutropin somatropin products including Nutropin AQ Pen 10 mg, Nutropin AQ Pen 20, and Nuspin somatropin cartridges to be used in your treatment program.

 

Reviews

There are no reviews yet.

Be the first to review “NUTROPIN INJECTIONS”

Your email address will not be published. Required fields are marked *

NO HGH PRESCRIPTION WILL BE PROVIDED UNLESS A CLINICAL NEED EXISTS BASED ON REQUIRED LAB WORK, PHYSICIAN CONSULTATION, PHYSICAL EXAMINATION AND CURRENT MEDICAL HISTORY. PLEASE NOTE, AGREEING TO LAB WORK AND PHYSICAL EXAM DOES NOT GUARANTEE A FINDING OF CLINICAL NECESSITY AND A PRESCRIPTION FOR HORMONE THERAPY, HORMONE REPLACEMENT TREATMENT OR PRESCRIPTION HORMONE MEDICATIONS INCLUDING TESTOSTERONE, HCG AND HUMAN GROWTH HORMONE (HGH INJECTIONS).

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. No claim or opinion on the HGH.BZ website is intended to be nor should it be construed to be medical advice or hormone diagnosis. Please consult with a healthcare professional before starting any therapeutic program including HRT – Hormone Replacement Therapy.